BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11989791)

  • 1. Inhibition of IL-8-mediated MAPK activation in human neutrophils by beta1 integrin ligands.
    Xythalis D; Frewin MB; Gudewicz PW
    Inflammation; 2002 Apr; 26(2):83-8. PubMed ID: 11989791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 cleavage in fMLP- and IL-8-induced chemotaxis is dependent on p38 MAP kinase but independent of p44/42 MAP kinase.
    Fujita T; Zawawi KH; Kurihara H; Van Dyke TE
    Cell Signal; 2005 Feb; 17(2):167-75. PubMed ID: 15494208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis.
    Ashida N; Arai H; Yamasaki M; Kita T
    J Biol Chem; 2001 May; 276(19):16555-60. PubMed ID: 11278464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous desensitization of IL-8-mediated chemotaxis in human neutrophils by a cell-binding fragment of fibronectin.
    Stanton KJ; Frewin MB; Gudewicz PW
    J Leukoc Biol; 1999 Apr; 65(4):515-22. PubMed ID: 10204581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells.
    Wuyts WA; Vanaudenaerde BM; Dupont LJ; Demedts MG; Verleden GM
    Respir Med; 2003 Jul; 97(7):811-7. PubMed ID: 12854631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAC1/P38 MAPK signaling pathway controls beta1 integrin-induced interleukin-8 production in human natural killer cells.
    Mainiero F; Soriani A; Strippoli R; Jacobelli J; Gismondi A; Piccoli M; Frati L; Santoni A
    Immunity; 2000 Jan; 12(1):7-16. PubMed ID: 10661401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.
    Coxon PY; Rane MJ; Uriarte S; Powell DW; Singh S; Butt W; Chen Q; McLeish KR
    Cell Signal; 2003 Nov; 15(11):993-1001. PubMed ID: 14499342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes.
    Forsyth CB; Pulai J; Loeser RF
    Arthritis Rheum; 2002 Sep; 46(9):2368-76. PubMed ID: 12355484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity.
    Reiling N; Blumenthal A; Flad HD; Ernst M; Ehlers S
    J Immunol; 2001 Sep; 167(6):3339-45. PubMed ID: 11544323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of neutrophils to anti-integrin antibodies depends on costimulation through low affinity Fc gamma Rs: full activation requires both integrin and nonintegrin signals.
    Jakus Z; Berton G; Ligeti E; Lowell CA; Mócsai A
    J Immunol; 2004 Aug; 173(3):2068-77. PubMed ID: 15265942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.
    Park J; Tadlock L; Gores GJ; Patel T
    Hepatology; 1999 Nov; 30(5):1128-33. PubMed ID: 10534331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment.
    Gemba T; Valbracht J; Alsalameh S; Lotz M
    J Biol Chem; 2002 Jan; 277(2):907-11. PubMed ID: 11677248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand density modulates eosinophil signaling and migration.
    Holub A; Byrnes J; Anderson S; Dzaidzio L; Hogg N; Huttenlocher A
    J Leukoc Biol; 2003 May; 73(5):657-64. PubMed ID: 12714581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
    Kozawa O; Hatakeyama D; Uematsu T
    J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
    Tokuda H; Kozawa O; Uematsu T
    J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connection between integrins and cell activation in rat adrenal glomerulosa cells: a role for Arg-Gly-Asp peptide in the activation of the p42/p44(mapk) pathway and intracellular calcium.
    Campbell S; Otis M; Côté M; Gallo-Payet N; Payet MD
    Endocrinology; 2003 Apr; 144(4):1486-95. PubMed ID: 12639933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway.
    Yang CM; Chien CS; Hsiao LD; Pan SL; Wang CC; Chiu CT; Lin CC
    Br J Pharmacol; 2001 Apr; 132(7):1531-41. PubMed ID: 11264247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways.
    Nagai N; Klimava A; Lee WH; Izumi-Nagai K; Handa JT
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1903-10. PubMed ID: 19011018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.